Cross-Border Impact Ventures (CBIV) today announced the final closing of its first fund after exceeding US$90 million in investor commitments. The Women’s and Children’s Health Technology Fund is focused on investments in technology companies that address the health needs of women, children, and adolescents or make health systems more resilient.
SAN FRANCISCO--(BUSINESS WIRE) Demy-Colton and EBD Group’s Biotech Showcase™, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees – including a record-breaking 1,285 investors and 110 members of the media
The Soluna California Cycle Tour, an inspiring collaboration with adventure cyclist Ed Hack to increase awareness about youth mental health, is underway in California. Known as a passionate mental health advocate, Ed is cycling across California to help promote Soluna, a free, safe, and confidential mental health app designed specifically for California youth ages 13-25.
The MEDITWIN consortium was announced on December 11, 2023, in the presence of French President Emmanuel Macron. More details were presented at the PariSanté Campus on December 14 in the presence of French Minister Delegate for Industry Roland Lescure.
NUS Nursing's SPA App shows positive outcomes for parents The Alice Lee Centre f…
Elation Health, the clinical-first technology company powering innovation in primary care, today announced the successful adoption of Surescripts Real-Time Prescription Benefit tool, expanding the offerings with the long-time ePrescribing partner.
Today, AllerVie Health, a leading national provider of allergy and immunology services, announced the extensive optimization of its digital infrastructure within clinics across 12 states in 2023.
In a significant move within the digital health space, Droobi Health, a startup in …
Yonsei University Health System (YUHS) is taking a groundbreaking step in expanding…
A recent Ipsos survey conducted by Danone found that more than 80 percent of cancer…